Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
naproxen sodium + pseudoephedrine (Hainan Helpson Medical & Biotechnology)
- Development stage
- Unknown
- Lead developer
- Bayer
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Naproxen sodium + pseudoephedrine is a fixed-dose combination pharmaceutical product developed by Hainan Helpson Medical & Biotechnology, a subsidiary of China Pharma Holdings. This combination therapy is designed for the symptomatic relief of the common cold and influenza (flu). It contains **naproxen sodium**, a nonsteroidal anti-inflammatory drug (NSAID) that provides analgesic, antipyretic, and anti-inflammatory effects by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), and **pseudoephedrine**, a sympathomimetic decongestant. Pseudoephedrine acts primarily on alpha-adrenergic receptors in the nasal mucosa to induce vasoconstriction, thereby reducing nasal congestion and improving sinus drainage. The product is formulated for oral administration and is marketed as an approved generic medication in China.
- Brand names
- 普森欧克
- Other names
- Naproxen Sodium + Pseudoephedrine
02
Targets
ADRA1 (Alpha-1 adrenergic receptor family)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on naproxen sodium + pseudoephedrine (Hainan Helpson Medical & Biotechnology).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on naproxen sodium + pseudoephedrine (Hainan Helpson Medical & Biotechnology).